Edition:
United States

Theravance Biopharma Inc (TBPH.OQ)

TBPH.OQ on NASDAQ Stock Exchange Global Market

25.90USD
20 Jul 2018
Change (% chg)

$-0.39 (-1.48%)
Prev Close
$26.29
Open
$26.27
Day's High
$26.37
Day's Low
$25.55
Volume
31,880
Avg. Vol
75,415
52-wk High
$38.35
52-wk Low
$21.27

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -1.14 December 21 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 2 2 2 2
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.75 2.75 2.75 2.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 13.24 19.10 9.60 3.64
Quarter Ending Dec-18 6 14.88 20.80 8.90 3.82
Year Ending Dec-18 6 46.72 64.10 36.50 50.84
Year Ending Dec-19 7 85.04 101.20 64.91 73.80
Earnings (per share)
Quarter Ending Sep-18 6 -1.14 -1.03 -1.21 -1.05
Quarter Ending Dec-18 6 -1.19 -1.00 -1.33 -0.95
Year Ending Dec-18 6 -4.73 -4.38 -5.03 -3.98
Year Ending Dec-19 7 -3.98 -3.07 -4.90 -3.87

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 6.43 8.32 1.89 29.32
Quarter Ending Dec-17 4.84 4.51 0.33 6.77
Quarter Ending Sep-17 4.61 4.28 0.33 7.22
Quarter Ending Jun-17 4.66 3.51 1.15 24.74
Quarter Ending Mar-17 5.57 3.09 2.49 44.62
Earnings (per share)
Quarter Ending Mar-18 -1.26 -1.22 0.04 -3.07
Quarter Ending Dec-17 -1.16 -1.64 0.48 -40.77
Quarter Ending Sep-17 -1.20 -1.12 0.08 -6.67
Quarter Ending Jun-17 -1.14 -1.27 0.13 -11.60
Quarter Ending Mar-17 -1.14 -1.27 0.13 -11.40

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 13.24 13.24 13.24 13.24 3.64
Quarter Ending Dec-18 14.88 14.88 14.88 14.88 3.82
Year Ending Dec-18 46.72 46.72 46.72 46.72 50.84
Year Ending Dec-19 85.04 85.04 85.04 85.04 73.80
Earnings (per share)
Quarter Ending Sep-18 -1.14 -1.14 -1.14 -1.14 -1.05
Quarter Ending Dec-18 -1.19 -1.19 -1.19 -1.19 -0.95
Year Ending Dec-18 -4.73 -4.73 -4.73 -4.73 -3.98
Year Ending Dec-19 -3.98 -3.98 -3.98 -3.98 -3.87

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0